RHOA, SEMA3B, and CKAP2 expression in leukaemia of different types: The results of a pilot experiment

Folia Biologica (Czech Republic)

Volumn 59, Issue 5, 2013, Pages 204-206

  Klimov, E A ^a   Selivanova, N L ^b   Razumnova, G I ^b   Rudko, O I ^a   Golovatenko Abramov, P K ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

Author keywords

CKAP2; Gene expression; Leukaemia; RHOA; RT PCR; SEMA3B

Indexed keywords

CYTOSKELETON ASSOCIATED PROTEIN 2; PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEMAPHORIN; SEMAPHORIN 3B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; LYMPHATIC LEUKEMIA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PILOT STUDY; PROTEIN EXPRESSION;

ADULT; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; MEMBRANE GLYCOPROTEINS; PILOT PROJECTS; PROTEIN ISOFORMS; RHOA GTP-BINDING PROTEIN; SEMAPHORINS;

EID: 84891436687     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Aznar, S., Fernández-Valerón, P., Espina, C., Lacal, J. C. (2004) Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 206, 181-191.
2. Bae, C. D., Sung, Y. S., Jeon, S. M., Suh, Y., Yang, H. K., Kim, Y. I., Park, K. H., Choi, J., Ahn, G., Park, J. (2003) Upregulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J. Cancer Res. Clin. Oncol. 129, 621-630.
3. Braga, E. A, Loginov, V. I., Klimov, E. A., Kilosanidze, G., Khodyrev, D. S., Kaganova, N. L., Kazybskaia, T. P., Ermilova, V. D., Gar'kavtseva, R. F., Pronina, I. V., Rud'ko, O. I., Zabarskiǐ, E. R., Sulimova, G. E., Kiselev, L. L. (2006) Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region. Mol. Biol. (Mosk.) 40, 865-877.
4. Castro-Rivera, E., Ran, S., Thorpe, P., Minna, J. D. (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl. Acad. Sci. USA 101, 11432-11437.
5. Etienne-Manneville, S., Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635.
6. Jin, Y., Murakumo Y., Ueno, K., Hashimoto, M., Watanabe, T., Shimoyama, Y., Ichihara, M., Takahashi, M. (2004) Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties. Cancer Sci. 95, 815-821.
7. Kamai, T., Kawakami, S., Koga, F., Arai, G., Takagi, K., Arai, K., Tsujii, T., Yoshida, K. I. (2003) RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int. 91, 234-238.
8. Lessey, E. C., Guilluy, C., Burridge, K. (2012) From mechanical force to RhoA activation. Biochemistry 51, 7420-7432.
9. Liu, N., Bi, F., Pan, Y., Sun, L., Xue, Y., Shi, Y., Yao, X., Zheng, Y., Fan, D. (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin. Cancer Res. 10, 6239-6247.
10. Maouche-Chrétien, L., Deleu, N., Badoual, C., Fraissignes, P., Berger, R., Gaulard, P., Roméo, P. H., Leroy-Viard, K. (1998) Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene 17, 1245-1251.
11. Pan, Y., Bi, F., Liu, N., Xue, Y., Yao, X., Zheng, Y., Fan, D. (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315, 686-691.
12. Parri, M., Chiarugi, P. (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal. 8, 23.
13. Pronina, I. V., Loginov, V. I., Prasolov, V. S., Klimov, E. A., Khodyrev, D. S., Kazubskaia, T. P., Gar'kavtseva, R. F., Sulimova, G. E., Braga, E. A. (2009) Alteration of SEMA3B gene expression levels in epithelial tumors. Mol. Biol. (Mosk.) 43, 439-445.
14. Rakhmanaliev, E. R., Klimov, E. A., Kompaniǐtsev, A. A., Sulimova, G. E. (2002) The structure of the human oncogenesis-associated CKAP2 (LB1) gene. Mol. Biol. (Mosk.) 36, 985-989.
15. Roche, J., Drabkin, H. A. (2001) The role of semaphorins in lung cancer. Clin. Lung Cancer 3, 145-150.
16. Tsuchihara, K., Lapin, V., Bakal, C., Okada, H., Brown, L., Hirota-Tsuchihara, M., Zaugg, K., Ho, A., Itie-Youten, A., Harris-Brandts, M., Rottapel, R., Richardson, C. D., Benchimol, S., Mak, T. W. (2005) Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner. Cancer Res. 65, 6685-6691.
17. Vial, E., Sahai, E., Marshall, C. J. (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-79.
18. Yazdani, U., Terman, J. R. (2006) The semaphorins. Genome Biol. 7, 211.